META (META) stock shares came under pressure Thursday after a Los Angeles jury found the company negligent in a landmark social media addiction trial, resulting in a $6 million verdict, while a separate New Mexico jury ordered Meta to pay $375 million for violating state child exploitation laws. The dual court rulings coincided with reports of 700 layoffs and China’s decision to bar the co-founders of AI startup Manus from leaving the country as regulators scrutinize Meta’s proposed $2.5 billion acquisition.

Key Drivers of the META Stock Move
- Main Catalyst: A one-two punch of legal liability: the Los Angeles addiction verdict and a $375M New Mexico child exploitation ruling arrived simultaneously with layoff reports and a geopolitical roadblock on the Manus acquisition, creating a multi-front news event that pushed shares sharply lower.
- Bull Case: Jim Cramer and CNBC’s Rob Sechan publicly called META a buy on the dip. Analysts maintain strong buy ratings with price targets as high as $945. Meta’s $10 billion West Texas data center expansion, its AI-at-work transformation under CTO Andrew Bosworth, a new ARM chip co-design partnership, and its $9 trillion valuation target via executive stock incentive plans all signal continued aggressive growth investment.
- Bear Case: Legal exposure is compounding. The social media addiction trial verdict may open the door to a wave of copycat litigation. China’s scrutiny of the Manus deal adds regulatory and geopolitical risk. Meta’s “Avocado” AI model reportedly lagged rivals Google and Anthropic in internal testing. Cathie Wood’s ARK trimmed its META position. And the company’s RSI has pushed into oversold territory, reflecting real selling pressure.

The current setup reflects a stock caught between two forces: genuine long-term AI infrastructure conviction and near-term headline risk from courts, regulators, and a macro backdrop featuring oil-driven stagflation fears and a weakening broader market. The legal trajectory deserves close attention. A $375M New Mexico verdict and a $6M Los Angeles award together may only be a preview if plaintiffs’ attorneys see a pattern of liability establishing itself across jurisdictions. Until that risk is better quantified, cautious positioning is defensible.
META Smart Money Activity
On the insider side, selling has been consistent and scheduled throughout 2026. COO Javier Olivan has disposed of roughly $1M in stock almost every single week since January. CFO Susan Li executed a large cluster of sales in late February, totaling over $83M across a few days. CTO Andrew Bosworth sold $5.1M in mid-February. These look largely pre-planned. However, on March 20, the company issued a broad suite of new stock option and RSA awards to virtually all senior officers, including COO, CTO, CFO, CPO, and CLO, suggesting the C-suite is being locked in for the long term. On the government side, five Democratic House members purchased META in January and February (including Rep. Cleo Fields with $100K-$250K on Feb. 3), while two members sold. Republican reps McCaul and Letlow also added small positions in February.

META Unusual Options
Options flow on March 26 was exceptionally heavy and skewed bearish. The two largest single prints of the session were a bearish $1.2M sweep on the Jun’26 $570 PUT and a bearish $1.1M sweep on the Nov’26 $480 PUT. A notable $836K bullish trade hit the Jun’26 $670 CALL at the ask. The biggest single print overall was a $984K neutral sweep on the same-day $585 PUT, followed by a $814K bearish sweep on the Jun’26 $560 PUT. Long-dated flow also appeared: a $1.2M trade hit the Jan’28 $500 PUT at the bid (tagged bullish, as sold-put), and a $2.3M bearish sweep hit the Jan’27 $500 CALL at the bid. Overall, put premium dominated the session, reflecting active downside hedging.

META Analyst Focus
All analyst actions since February have been confirmations of Buy ratings, with no downgrades recorded. Tigress Financial Partners raised its Strong Buy target to $945, while Wells Fargo increased its Buy target to $856. Freedom Broker lifted its target to $825, and Argus Research maintained a Buy at $800. Overall, the median price target is around $850; with Meta Platforms trading near $550, this implies roughly 55% upside, highlighting strong analyst conviction despite potential near-term risks.

META Seasonality
Based on data since January 2013 (13-14 samples per month). March sits at the seasonal low for META, with a 50% win rate and an average change of -0.9%, meaning historically this month is a coin flip that leans slightly negative. The good news: April has historically been a strong turnaround month, with a 62% win rate and +4.3% average gain. If the legal and macro noise clears heading into Q2, seasonality is supportive for a recovery.

META Relative Performance
META’s yearly relative performance rank versus its own sector started 2026 near the 55th percentile, briefly spiked to ~64 following the January earnings beat, then steadily eroded through February and March. As of March 26, it sits at ~50, meaning META is now only outperforming about half of its sector peers on a trailing-year basis. That is a meaningful deterioration from its post-earnings peak, and it aligns technically with the broader selling pressure seen this week. META is no longer a clear sector leader on a price basis, at least for now.